Aaron I. Davis, Director, 10% Owner at Odonate Therapeutics, Inc. (ODT), bought 416,666 shares at $24.00 ($10.0M) on 2017-12-06, disclosed to the SEC on 2017-12-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| TYRA | SELL | 2023-02-13 | $4.4M | — | Filing → |
| RAIN | BUY | 2022-11-08 | $11.3M | — | Filing → |
| ITOS | SELL | 2022-05-11 | $20.2M | — | Filing → |